Keeley, E.C. and Grines, C.L. (2004) Primary Percutaneous Coronary Intervention for Every Patient with St-Segment Elevation Myocardial Infarction: What Stands in the Way? Annals of Internal Medicine, 141, 298-304.
https://doi.org/10.7326/0003-4819-141-4-200408170-00010

has been cited by the following article:

• TITLE: Use of Beta-Blocker in Acute ST-Elevation Myocardial Infarction

  AUTHORS: Daiyuan Wang, Jing Wang

  KEYWORDS: Beta-Blocker, Acute Myocardial Infarction

  JOURNAL NAME: World Journal of Cardiovascular Diseases, Vol.14 No.8, August 16, 2024

  ABSTRACT: This paper reported beta-blocker use in 21 STEMI patients over four years. The patients were between 50 - 65 years of age presenting with anterior, lateral, and inferior STEMI (ST-Elevation Myocardial Infarction). Seven of the patients were female, and 14 were male. They presented to an emergency room of a rural hospital that did not provide emergency percutaneous coronary angioplasty/stenting (PTCA/stenting). The hospital is about 70 minutes from a facility that provided PTCA/ stenting—all the patients presented with typical angina chest pain with ST elevation. They are hemodynamic stable. Most patients received Lopressor 35 mg IVP, with one receiving 115 mg in a 5 mg increment. They were chest pain-free and hemodynamically before leaving the ER for the transfer for PTCA/stent. The results demonstrated that beta-blockers are effective in relieving pain in STEMI patients. Further study is needed to determine its efficacy, safety, and how to use it.